Brandinium

Trademark search for:

BIOLED

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2010-07-28 — Application filed
  • 2011-03-10 — Sn assigned for sect 66a appl from ib
  • 2011-03-11 — Application filed
  • 2011-03-11 — Assigned to examiner
  • 2011-03-15 — Application filed
  • 2011-03-21 — Final disposition recorded
  • 2011-03-22 — Office action issued
  • 2011-03-23 — Office action issued
  • 2011-03-24 — Office action issued
  • 2011-04-17 — Office action issued
  • 2011-09-26 — Attorney/dom.rep.revoked and/or appointed
  • 2011-09-26 — Fax received
  • 2011-09-26 — Teas revoke/app/change addr of atty/dom rep received
  • 2011-09-27 — Amendment from applicant entered
  • 2011-09-27 — Assigned to lie
  • 2011-09-27 — Correspondence received in law office
  • 2011-12-07 — Office action issued
  • 2011-12-07 — Office action issued
  • 2011-12-07 — Office action issued
  • 2012-05-25 — Limitation of goods received from ib
  • 2012-06-06 — Teas request for reconsideration received
  • 2012-06-07 — Exparte appeal received at ttab
  • 2012-06-07 — Jurisdiction restored to examining attorney
  • 2012-06-07 — Ex parte appeal-instituted
  • 2012-06-08 — Teas/email correspondence entered
  • 2012-06-08 — Correspondence received in law office
  • 2012-07-17 — Limitation from the ib examined and entered
  • 2012-07-23 — Final disposition recorded
  • 2012-07-23 — Notification of action denying req for recon e-mailed
  • 2012-07-23 — Action denying req for recon e-mailed
  • 2012-08-15 — Notification of possible opposition sent to ib
  • 2012-08-15 — Notification of possible opposition created, to be sent to ib
  • 2012-08-31 — Notification of possible opposition - processed by ib
  • 2012-10-17 — Exparte appeal dismissed - failure to file brief
  • 2012-12-03 — Exparte appeal terminated
  • 2012-12-07 — Examiners amendment -written
  • 2012-12-07 — Examiners amendment e-mailed
  • 2012-12-07 — Notification of examiners amendment e-mailed
  • 2012-12-07 — Examiner's amendment entered
  • 2012-12-12 — Approved for pub - principal register
  • 2012-12-14 — Law office publication review completed
  • 2013-01-02 — Notification of possible opposition sent to ib
  • 2013-01-02 — Notification of notice of publication e-mailed
  • 2013-01-02 — Notice of start of opposition period created, to be sent to ib
  • 2013-01-22 — Published for opposition
  • 2013-01-22 — Official gazette publication confirmation e-mailed
  • 2013-04-09 — Registered-principal register
  • 2013-07-09 — Final disposition recorded
  • 2013-07-12 — Final disposition recorded
  • 2013-07-12 — Final disposition recorded
  • 2013-08-04 — Final disposition recorded
  • 2018-04-09 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2019-11-15 — Cancelled section 71
  • 2020-07-15 — Total invalidation of reg ext protection created
  • 2020-07-28 — Final status recorded
  • 2020-08-11 — Invalidation processed
  • 2020-08-12 — Total invalidation of reg ext protection sent to ib
  • 2020-09-01 — Irregularity on invalidation received from ib
  • 2021-08-14 — Death of international registration
  • 2021-08-14 — Notification of effect of cancellation of intl reg e-mailed

Owner Information

Molecular Vision Limited
London SW7 2BP GB
Molecular Vision Limited
London SW7 2BP GB
Molecular Vision Limited
London SW7 2BP GB

Correspondent

DAVID A. BELL HAYNES AND BOONE, LLP
2323 VICTORY AVENUE, SUITE 700
DALLAS, TX 75219-7673
UNITED STATES

Filing Details

Filing Date:
2010-07-28
Status Date:
2020-07-28
Filing Year:
2010

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.